Do you think dolphins have good skin? It turns out that dolphins have a recently discovered fatty acid, C-15, that is linked to anti-aging benefits and holistic wellness. C-15 is the first newly discovered essential fatty acid identified in nearly a century. Pentadecanoic acid, also known as C-15, is an essential fatty acid that defies the norms of cellular fortification.In this episode of the Biohacking Beauty podcast, Amitay, CEO of Young Goose, sits down with Dr. Stephanie Venn Watson of Seraphina Therapeutics to discuss C-15 and its potential benefits of lowering cholesterol, reducing inflammation, decreasing tissue scarring, and its assistance with reducing the risk of diseases like type 2 diabetes, heart disease, and fatty liver disease. Listen in as we discuss the important role that C-15 might play in mood disorders and cognitive health, as well as the implications it may have on skincare science in the future. The future of C-15 research could help personalize supplementation for optimal health outcomes and better dietary recommendations, while potentially addressing deficiencies more effectively.What we discuss: (4:46) An introduction to C-15, the first essential fatty acid to be discovered in 90 years(8:11) Understanding dolphin aging and health, and its impact on C-15 fatty acid(11:44) How Dolphins diet impact their levels of C-15 and downstream healthy aging benefits(13:47) The benefits of C-15, the stable fatty acid, on our cells(20:01) C15 and it’s holistic health snapshot in conjunction with diet and exercise (25:42) Success stories from users of C-15 and the anti-aging benefits of taking C-15 (30:23) How C-15 and fatty acids impact brain health(35:18) How to properly dose C-15 for maximum benefits on your health(38:59) Balancing omega-3s for mood regulation(44:20) C-15 positives and negatives, and why continuing studies are emerging new benefits(47:30) Cell death and how C-15 repairs the mitochondria, amongst other benefits(49:06) Biostacking and the fad of combining therapies(56:35) The opportunities of C-15 to help with mental and cognitive health, as well as potentially skincareDr. Stephanie Venn Watson is a serial entrepreneur who has successfully launched Epitracker, Seraphina Therapeutics, two clinical research programs within the Department of Defense and non-profit sector and founded public health education programs in the community and at the Centers for Disease Control and Prevention. Her novel approach to discovering therapeutic candidates for animals and humans has been featured on NPR’s Science Friday, CBS, BBC, National Geographic, Biocom’s Annual Dinner (2014), J&J Innovations: Powerful Ideas Series (2015), San Diego Venture Group’s Hot Topic Series (2015) and Cool Companies (2017), LA BioMed Innovation Showcase (2016), and San Diego’s Innovation Showcase (2017). She has over 60 peer-reviewed scientific publications and book chapters and is the lead inventor on over 40 issued and pending patents. For her entrepreneurial work in the health industry, Stephanie was awarded the Department of Human and Human Services Secretary’s Award for Innovations in Disease Prevention and Health Promotion.To learn more about Young Goose:Use code PODCAST10 to get 10% off your first purchase, and if you’re a returning customer use the code PODCAST5 to get 5% off at https://www.younggoose.com/Instagram: @young_goose_skincareTo learn more about Dr. Stephanie Venn Watson: Seradina Therapeutics: https://seraphinatherapeutics.com/Resources:Spermidine research:

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.